From the 2/12/2021 release of VAERS data:

Found 34 cases where Vaccine is COVID19 and Symptom is Aborted pregnancy or Abortion or Abortion spontaneous or Abortion spontaneous complete or Abortion spontaneous incomplete or Abortion threatened or Foetal-maternal haemorrhage or Foetal cardiac disorder or Foetal damage or Foetal death or Foetal disorder or Foetal distress syndrome or Foetal heart rate abnormal or Foetal heart rate deceleration or Foetal heart rate deceleration abnormality or Foetal heart rate decreased or Foetal heart rate disorder or Foetal heart rate increased or Foetal hypokinesia or Foetal malformation or Foetal malpresentation or Foetal monitoring abnormal or Foetal movement disorder or Foetal movements decreased or Foetal non-stress test abnormal or Placental disorder or Pregnancy induced hypertension or Premature baby or Premature baby death or Premature delivery or Premature labour or Premature rupture of membranes or Premature separation of placenta or Stillbirth or Ultrasound foetal abnormal

Age	Count	Percent
17-44 Years	33	97.06%
Unknown	1	2.94%
TOTAL	34	100%

This is page 1 out of 4

VAERS ID: 906529 (history)   Form: Version 2.0   Age: 34.0   Sex: Female   Location: Texas   Vaccinated: 2020-12-18 Onset: 2020-12-19    Days after vaccination: 1 Submitted: 0000-00-00 Entered: 2020-12-22 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 RA / IM Administered by: Private       Purchased by: ? Symptoms: Exposure during pregnancy, Premature delivery, Premature labour, Premature rupture of membranes SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, 4 days    Extended hospital stay? No Previous Vaccinations: Other Medications: Claritin, Prenatal Vitamins, Flonase Current Illness: no Preexisting Conditions: no Allergies: no Diagnostic Lab Data: No CDC Split Type: vsafe Write-up: When I got the vaccination I was 32weeks pregnant and on Saturday I had spontaeous rupture of the amnotic fluids and went immediately to the hospital and was immediately given steroid, magnesium for the baby. And on Sunday around 3:45PM I got a second round of the steroids and was transferred for observation. On Monday, at 8:06am I went into early labor I delivered my baby at 33weeks gestation and she weighed 3lb 11oz. Expected Date of Delivery-2/8/2021. I was a high risk patient d/t Fibroids but have experienced no issues the entire pregnancy and my last ultrasound was 12/17 and baby was healthy with no complications at that time.

VAERS ID: 916065 (history)   Form: Version 2.0   Age: 37.0   Sex: Female   Location: Washington   Vaccinated: 2020-12-27 Onset: 2020-12-28    Days after vaccination: 1 Submitted: 0000-00-00 Entered: 2020-12-31 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 037K20A / 1 LA / SYR Administered by: Other       Purchased by: ? Symptoms: Exposure during pregnancy, Foetal monitoring, Hydrops foetalis, Premature labour SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? No Previous Vaccinations: Other Medications: Zofran 2weeks prior, Multivatamins Current Illness: none Preexisting Conditions: Allergies: Sulfa, Vicodin, Neosporin Diagnostic Lab Data: CDC Split Type: Write-up: EDD - 4/1/2021 - Contractions at 26 w 3 days sent to L&D to be monitored on 12/28/20. Covid-19 Sars Vaccine given 1st dose 12/27/20. Patient was diagnosed with Fetal Hydrops. Patient Hospitalized 12/28/20 - current MFM consulting in hospital & outpatient

VAERS ID: 918034 (history)   Form: Version 2.0   Age: 35.0   Sex: Female   Location: Michigan   Vaccinated: 2020-12-23 Onset: 2020-12-25    Days after vaccination: 2 Submitted: 0000-00-00 Entered: 2021-01-03 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ1685 / 1 LA / IM Administered by: Pharmacy       Purchased by: ? Symptoms: Exposure during pregnancy, Foetal death, Foetal heart rate abnormal, Foetal hypokinesia, Premature delivery, Stillbirth, Ultrasound Doppler, Ultrasound foetal SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? Yes Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, 1 days    Extended hospital stay? No Previous Vaccinations: Other Medications: Advair, Pulmocort, levothyroxine, pepcid, prenatal vitamins, singulair, aspirin Current Illness: None Preexisting Conditions: Asthma Allergies: None Diagnostic Lab Data: Fetal doppler and fetal ultrasound on 12/26/2020 CDC Split Type: Write-up: I was 28 weeks and 5 days pregnant when I received the first dose of the COVID19 vaccine. Two days later (12/25/2020 in the afternoon), I noticed decreased motion of the baby. The baby was found to not have a heartbeat in the early am on 12/26/2020 and I delivered a 2lb 7oz nonviable female fetus at 29 weeks gestation. I was 35 years old at the time of the fetal demise and the only pregnancy history for this pregnancy included a velamentous cord insertion that was being closely monitored by a high risk OB. My estimated due was March 12, 2021.

VAERS ID: 922289 (history)   Form: Version 2.0   Age: 34.0   Sex: Female   Location: California   Vaccinated: 2020-12-17 Onset: 2020-12-31    Days after vaccination: 14 Submitted: 0000-00-00 Entered: 2021-01-06 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK5730 / 1 LA / IM Administered by: Private       Purchased by: ? Symptoms: Abdominal pain, Abortion spontaneous, Human chorionic gonadotropin decreased, Ultrasound antenatal screen abnormal, Uterine haemorrhage SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow), Fertility disorders (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Pre natal vitamins Current Illness: No Preexisting Conditions: No Allergies: No Diagnostic Lab Data: Falling HCG level Transactional ultrasound confirmed miscarriage CDC Split Type: Write-up: I suffered a miscarriage on 12/31/2020. I was at 5 weeks gestation. This was my first pregnancy. I had uterine bleeding and abdominal cramps on 12/31/2020 and underwent evaluation by my Obstetrician and was diagnosed with a miscarriage after ultrasound.

VAERS ID: 925639 (history)   Form: Version 2.0   Age: 34.0   Sex: Female   Location: Idaho   Vaccinated: 2020-12-22 Onset: 2020-12-22    Days after vaccination: 0 Submitted: 0000-00-00 Entered: 2021-01-07 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0140 / 1 RA / OT Administered by: Private       Purchased by: ? Symptoms: Abortion spontaneous, Exposure during pregnancy SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: Current Illness: Sleep apnoea Preexisting Conditions: Allergies: Diagnostic Lab Data: Test Name: tested for COVID-19; Result Unstructured Data: Test Result:Unknown results; Test Date: 20201228; Test Name: Nasal Swab; Test Result: Negative CDC Split Type: USPFIZER INC2021000238 Write-up: Miscarriage; patient was pregnant while taking BNT162B2; patient was pregnant while taking BNT162B2; This is a spontaneous report from a contactable Other Health Professional. A 34-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0140), intramuscularly on 22Dec2020 06:00 AM at single dose at Arm Right at Hospital for COVID. Medical history included ongoing sleep apnoea. There were no concomitant medications. There were no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced miscarriage on 29Dec2020 13:00. The patient was pregnant while taking BNT162B2. The patient was 4 Weeks pregnant at the onset of the event. Patient last menstrual period date was 24Nov2020. The Pregnancy due to deliver was on 07Sep2021. The pregnancy resulted in spontaneous abortion. Since the vaccination, the patient has been tested for COVID-19 on an unknown date with unknown results. Nasal Swab on 28Dec2020 was Negative. There was no treatment received for the adverse event. The outcome of event was recovering.; Sender''s Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to agency, Ethics Committees, and Investigators, as appropriate.

VAERS ID: 928892 (history)   Form: Version 2.0   Age: 35.0   Sex: Female   Location: Georgia   Vaccinated: 2020-12-20 Onset: 2021-01-08    Days after vaccination: 19 Submitted: 0000-00-00 Entered: 2021-01-08 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ1685 / 1 LA / IM Administered by: Work       Purchased by: ? Symptoms: Abortion spontaneous, Exposure during pregnancy, Ultrasound antenatal screen abnormal SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow), Termination of pregnancy and risk of abortion (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? Yes Office Visit? Yes ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: Pre-natal MVI, Iron supplement, B6 50mg BID Current Illness: None Preexisting Conditions: None Allergies: amoxicillin-clavulanate Diagnostic Lab Data: Ultrasound 12/18 Pregnant, Estimated 6w3d Ultrasound 01/08 No pregnancy observed CDC Split Type: Write-up: I was approximately six weeks pregnant at time of my first vaccine. At subsequent OB visit three weeks later I had miscarried. It may not be related to the vaccine at all, but given this is a new vaccine and not studied in pregnant women I thought it was best to report it.

VAERS ID: 930916 (history)   Form: Version 2.0   Age: 32.0   Sex: Female   Location: New Mexico   Vaccinated: 2021-01-07 Onset: 2021-01-08    Days after vaccination: 1 Submitted: 0000-00-00 Entered: 2021-01-09 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 AR / IM Administered by: Private       Purchased by: ? Symptoms: Abdominal pain, Exposure during pregnancy, Premature baby, Premature delivery, Vaginal haemorrhage SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Neonatal disorders (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, 2 days    Extended hospital stay? No Previous Vaccinations: Other Medications: prenatal vitamin calcium supplement 1200 mg vitamin d3 1000 iu Aspirin 81 mg Current Illness: none Preexisting Conditions: none Allergies: NKA Diagnostic Lab Data: see above CDC Split Type: Write-up: Patient is a 32 yo G2P1001 with EDD 5/2/2021 by 7w US. She had the first dose of the Pfizer Covid 19 vaccination on 12/17/2020 at the Health Clinic and the second dose on 1/7/2021 at 1115 am. She began having abdominal pain and vaginal bleeding at 315 sm on 1/8/2021 progressing to a previable (22w2d) preterm birth at 739pm on 1/8/2021.

VAERS ID: 932107 (history)   Form: Version 2.0   Age: 37.0   Sex: Female   Location: New York   Vaccinated: 2021-01-06 Onset: 2021-01-08    Days after vaccination: 2 Submitted: 0000-00-00 Entered: 2021-01-10 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / - Administered by: Private       Purchased by: ? Symptoms: Abortion spontaneous, Exposure during pregnancy, Muscle spasms SMQs:, Dystonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow) Life Threatening? No Birth Defect? Yes Died? No Permanent Disability? No Recovered? No Office Visit? Yes ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: Fluticasone, azelastine, prenatal vitamin Current Illness: None Preexisting Conditions: None Allergies: None Diagnostic Lab Data: CDC Split Type: Write-up: Pfizer-BioNTech COVID-19 Vaccine EUA Miscarriage - (date of vaccination 1/6/21, miscarriage symptoms (cramping) started 1/8/21, confirmed 1/10/21; estimated date of delivery 8/30/21)

VAERS ID: 943837 (history)   Form: Version 2.0   Age: 32.0   Sex: Female   Location: Massachusetts   Vaccinated: 2021-01-07 Onset: 2021-01-12    Days after vaccination: 5 Submitted: 0000-00-00 Entered: 2021-01-14 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3248 / 1 LA / IM Administered by: Pharmacy       Purchased by: ? Symptoms: Abortion spontaneous, Exposure during pregnancy, Haemorrhage, Human chorionic gonadotropin negative, Ultrasound scan vagina abnormal SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? Yes ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: Levetiracetam 500mg , Folic acid 4mg, prenatal vitamin, vitamin C 500mg, Zinc 50mg, Omega 3 fatty acids Current Illness: Preexisting Conditions: Seizure disorder Allergies: Amoxicillin Diagnostic Lab Data: 1/13/2021: Intravaginal ultrasound showing no gestational sac or embryo which would have been expected for gestation 1/13/2021: Hcg, Total, Quantitative 971 mIU/mL CDC Split Type: Write-up: Approximately 5 days after administration at 6 weeks pregnant, I began bleeding. The following day (6 days after administration) miscarriage was confirmed via ultrasound

VAERS ID: 947550 (history)   Form: Version 2.0   Age: 29.0   Sex: Female   Location: Idaho   Vaccinated: 2020-12-18 Onset: 2020-12-18    Days after vaccination: 0 Submitted: 0000-00-00 Entered: 2021-01-15 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / OT Administered by: Private       Purchased by: ? Symptoms: Exposure during pregnancy, Premature rupture of membranes SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? No Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: Medical History/Concurrent Conditions: Cold sores Allergies: Diagnostic Lab Data: CDC Split Type: USPFIZER INC2021015910 Write-up: spontaneous rupture of membranes at 36-0 weeks; Pregnant at the time of vaccination?: Yes; This is a spontaneous report from a contactable physician. This physician reported information for both mother and fetus/baby. This is the maternal report. A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular (left arm) on 18Dec2020 and 08Jan2021 at a single dose for COVID-19 immunization. Medical history included cold sores, no active cold sore at time of labor. On an unspecified date, it was reported that a healthy 29-year-old G1P0 with good prenatal care and no pregnancy complications who had spontaneous rupture of membranes at 36-0 weeks, one day after her second Pfizer CoVid vaccine (09Jan2021). She felt well after her vaccine and had no symptoms today. The mother reported she became pregnant while taking BNT162B2. The patient takes prenatal vitamins. The mother was 33 Weeks pregnant at the onset of the event. The mother was due to deliver on 06Feb2021. Therapeutic measures were taken as a result of premature rupture of membranes. The outcome of the event was recovering. Information about Batch/Lot number has been requested.; Sender''s Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of spontaneous rupture of membranes due to temporal relationship. However, the reported event may possibly represent intercurrent medical condition in this patient. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

New Search